Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in Mexico

INTRODUCTION AND OBJECTIVES: The emergence of SARS-CoV-2, which causes the coronavirus disease (COVID-19) has caused a great impact on healthcare systems worldwide, including hepatitis B and C viruses screening and elimination programs. The high number of COVID-19 hospitalizations represent a great...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Mendoza, JC, Rivera-López, FE, González-Lara, MF, Valdez-Echeverría, RD, Castro-Narro, GE, Tore, A, Uscanga-Domínguez, LF, Moctezuma-Velázquez, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of Fundación Clínica Médica Sur, A.C. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839798/
https://www.ncbi.nlm.nih.gov/pubmed/35167956
http://dx.doi.org/10.1016/j.aohep.2022.100684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839798/
https://www.ncbi.nlm.nih.gov/pubmed/35167956
http://dx.doi.org/10.1016/j.aohep.2022.100684

Ejemplares similares